- Home
- IMNM vs ARR Comparison
IMNM vs ARR Comparison
Compare IMNM & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMNM | ARR |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | ARR |
|---|---|---|
| Price | $22.66 | $19.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $31.22 | $18.17 |
| AVG Volume (30 Days) | 2.5M | ★ 3.9M |
| Earning Date | 11-06-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 15.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.65 |
| Revenue | $9,679,000.00 | ★ $116,798,000.00 |
| Revenue This Year | N/A | $296.22 |
| Revenue Next Year | $11.53 | $99.47 |
| P/E Ratio | ★ N/A | $29.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.15 | $13.18 |
| 52 Week High | $25.30 | $19.31 |
Technical Indicators
Market Signals| Indicator | IMNM | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 79.05 |
| Support Level | $20.05 | $18.38 |
| Resistance Level | $22.01 | $18.33 |
| Average True Range (ATR) | 1.28 | 0.36 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 82.00 | 93.22 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.